Vaping Addiction Class Action Lawsuit Filed Against JUUL, Altria and Philip Morris

JUUL and other e-cigarette manufacturers face a class action lawsuit pursuing damages for individuals who have become addicted to vaping, or who have fallen ill due to use of the devices.

The complaint (PDF) was filed by Shawn Hochhauser in the U.S. District Court for the Eastern District of New York on October 1, naming JUUL Labs, Inc. Altria Group, Inc. and Philip Morris USA Inc. as defendants.

Hochhauser is seeking class action status to pursue damages for all New York state citizens injured by electronic Nicotine Delivery Systems (ENDS). It also seeks to represent anyone in the state who, at least one time, purchased vaping products under the age of 18.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The lawsuit indicates the actions of the manufacturers led to a vaping addiction epidemic in the United States, leading to widespread underage use and various adverse health effects.

“Defendants’ unlawful practices have led to an epidemic of individuals addicted to e-cigarettes and vaping, to their severe detriment,” the lawsuit states. “Defendants based their conduct on decades of research by the tobacco industry about how to manipulate individuals into becoming addicted to their nicotine-containing products.”

The lawsuit calls the marketing of JUUL and other e-cigarette products deceptive and fraudulent. It also blames the manufacturers for failing to adequately test and research their products, pointing to an ongoing vaping pulmonary lung disease outbreak which has sickened more than 1000 people nationwide.

Due to increasing concerns about the potential side effects of JUUL and use among teens, the manufacturer recently announced that it will suspend all broadcast, print and digital marketing in the United States.

In addition to lung problems from vaping and addiction problems, federal regulators are also investigating other health concerns. In August 2019, the FDA indicated it had received at least 127 reports of seizures from vaping, and it is widely expected that number has risen dramatically in recent months as consumer awareness has increased about the dangers of e-cigarettes.

Last week, the U.S. Judicial Panel on Multidistrict Litigation decided to consolidate all JUUL lawsuits pending throughout the federal court system, centralizing the litigation before one judge in California for coordinated discovery and pretrial proceedings.

As more parents and young adults learn that their JUUL addiction and various lung problems may have been caused by a coordinated marketing effort by the manufacturer, it is widely expected that thousands of claims will be filed nationwide.

This latest class action lawsuit presents claims for negligence, violations of New York General Business laws, fraud, failure to warn, defective design, unjust enrichment, breach of warranty and public nuisance, seeking both compensatory and punitive damages.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 2 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 2 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.